Welcome to the 7th Annual Compound Management & Integrity…

The 7th Annual Pharma IQ Compound Management & Integrity conference has been established within the biopharma R&D community as the meeting place to discuss today’s most pressing issues on how to efficiently supply quality compound to support hit finding efforts and the drug discovery process.

Directors, Scientists and Managers working in Compound Management, Lead Discovery, Screening, IT, Engineering, Automation, Medicinal and Analytical Chemistry convene every year in London.

» Download the full agenda.

New Speakers, New Sessions and New Focused Tracks for the 7th Annual Compound Management & Integrity include:

• Creating Flexible, Process Driven CM Operations to Meet Evolving Customer Demands

• Using the Right Quality Control and Analytical Tools to Ensure High Quality Compounds and Successful Screening Results

• Integrating Workflows with Discovery Processes and Teams to Increase CM’s Impact on Research Results

• Assessing Current Outsourcing and Sourcing Strategies to Facilitate Beneficial External Collaborations and Optimal CM & Library Operations

» Download the full agenda.

Key highlights for the 7th Annual Compound Management & Integrity include:

• Abbott Laboratories is using pre-configured plates of compounds solvated in DMSO enabled high-throughput automation and retrieving up to 50,000 compounds a day
• Genentech is integrating new automation pieces with its existing workflow management/compound inventory system
• GlaxoSmithKline is adapting its processes with customers to provide "customised sets" with often different plate and compound formats
• Elan Pharmaceuticals is delivering flexible services to multiple groups and fast, as well as planning the physical and informatics integration of 80,000 new compounds
• Novartis is implementing a walk-up open-access UPLC/MS system for QC in the chemistry laboratory

» Download the full agenda.

Testimonials